Literature DB >> 10755255

Irritable bowel syndrome in patients with dyspepsia: a community-based study in southern Europe.

A M Caballero-Plasencia1, S Sofos-Kontoyannis, M Valenzuela-Barranco, J L Martín-Ruiz, F J Casado-Caballero, J G López-Mañas.   

Abstract

OBJECTIVES: Dyspepsia and irritable bowel syndrome (IBS) share aetiopathogenic factors, and may therefore be part of a single disorder. This study was intended to determine their prevalence in the general population, and the degree of overlap between these two digestive disorders.
DESIGN: Descriptive study.
METHODS: A sample of 264 subjects chosen randomly from the population census of a city in Spain, and considered representative of the general population in this city, was surveyed by questionnaire.
RESULTS: The prevalence of dyspepsia was 23.9%, and that of IBS was 13.6%. Of the subjects with dyspepsia, 31.6% had IBS, and of the subjects with IBS, 55.6% reported symptoms of dyspepsia. The prevalence of IBS was higher among subjects with dyspepsia (31.7%) than among those who reported no symptoms of dyspepsia (7.9%; P < 0.05). Moreover, the prevalence of IBS was similar in three subgroups identified according to the type of dyspepsia described (ulcer-like, reflux-like or dysmotility-like). When we compared subjects with both dyspepsia and IBS and those with dyspepsia alone, we found no significant differences in clinical characteristics except for abdominal pain and fear of cancer, which were more frequent in the former. Of the entire sample, 27.7% of the subjects sought medical attention for IBS and 17% missed work because of IBS.
CONCLUSION: Our findings suggest that functional dyspepsia and IBS are two manifestations of a single, more extensive digestive system disorder.

Entities:  

Mesh:

Year:  1999        PMID: 10755255     DOI: 10.1097/00042737-199905000-00009

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  19 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and "overlap syndrome" among african americans compared to Caucasians: a population-based study.

Authors:  Anil Minocha; William Chad; Wigington Do; William D Johnson
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  The challenges of evolving Rome criteria for functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-14

4.  Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility.

Authors:  Zoltán S Zádori; Ágnes Fehér; Viktória E Tóth; Mahmoud Al-Khrasani; László Köles; Szabina Sipos; Fabio Del Bello; Maria Pigini; Klára Gyires
Journal:  Dig Dis Sci       Date:  2016-02-10       Impact factor: 3.199

5.  Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization.

Authors:  Uri Ladabaum; Erin Boyd; Wei K Zhao; Ajitha Mannalithara; Annie Sharabidze; Gurkirpal Singh; Elaine Chung; Theodore R Levin
Journal:  Clin Gastroenterol Hepatol       Date:  2011-08-24       Impact factor: 11.382

Review 6.  Epidemiology of functional dyspepsia: a global perspective.

Authors:  Sanjiv Mahadeva; Khean-Lee Goh
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

7.  Quality of life in functional dyspepsia.

Authors:  Joan Monés; Ana Adan; José L Segú; Juan S López; Maite Artés; Tina Guerrero
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

8.  Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.

Authors:  Juan Zeng; Xiu-Li Zuo; Yan-Qing Li; Wei Wei; Guo-Ping Lv
Journal:  Eur J Clin Pharmacol       Date:  2007-03-20       Impact factor: 2.953

Review 9.  Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?

Authors:  Anna Matheis; Ute Martens; Johannes Kruse; Paul Enck
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

10.  Risk factors for un-investigated dyspepsia among primary care patients in northern Nigeria.

Authors:  O A Solomon; A O Ajayi
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.